Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Mease

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Clinical Rheumatology|September 8, 2018
Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trialJ A Walsh, A B Gottlieb, B Hoepken, et al.
Annals of the Rheumatic Diseases|February 15, 2005
OMERACT 7 psoriatic arthritis workshop: synopsisD D Gladman, V Strand, P J Mease, et al.
Lancet (London, England)|September 6, 2000
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trialP J Mease, B S Goffe, J Metz, et al.
Journal of General Internal Medicine|July 1, 1991
Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritisW J Katon, D S Buchwald, G E Simon, et al.
Annals of Internal Medicine|September 15, 1991
Natural history of the eosinophilia-myalgia syndromeR C Culpepper, R G Williams, P J Mease, et al.
Annals of the Rheumatic Diseases|October 19, 2006
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis TrialD D Gladman, P J Mease, M A Cifaldi, et al.
Arthritis Care & Research|October 4, 2016
Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic ArthritisD van der Heijde, A Deodhar, R Fleischmann, et al.
Clinical Rheumatology|October 14, 2016
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose groupR Fleischmann, P J Mease, S Schwartzman, et al.
Annals of the Rheumatic Diseases|April 29, 2006
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitorsJ Fransen, C Antoni, P J Mease, et al.
Annals of the Rheumatic Diseases|August 6, 2008
Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability studyP J Mease, K Hobbs, A Chalmers, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Clinical Rheumatology|September 8, 2018
Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trialJ A Walsh, A B Gottlieb, B Hoepken, et al.
Annals of the Rheumatic Diseases|February 15, 2005
OMERACT 7 psoriatic arthritis workshop: synopsisD D Gladman, V Strand, P J Mease, et al.
Lancet (London, England)|September 6, 2000
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trialP J Mease, B S Goffe, J Metz, et al.
Journal of General Internal Medicine|July 1, 1991
Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritisW J Katon, D S Buchwald, G E Simon, et al.
Annals of Internal Medicine|September 15, 1991
Natural history of the eosinophilia-myalgia syndromeR C Culpepper, R G Williams, P J Mease, et al.
Annals of the Rheumatic Diseases|October 19, 2006
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis TrialD D Gladman, P J Mease, M A Cifaldi, et al.
Arthritis Care & Research|October 4, 2016
Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic ArthritisD van der Heijde, A Deodhar, R Fleischmann, et al.
Clinical Rheumatology|October 14, 2016
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose groupR Fleischmann, P J Mease, S Schwartzman, et al.
Annals of the Rheumatic Diseases|April 29, 2006
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitorsJ Fransen, C Antoni, P J Mease, et al.
Annals of the Rheumatic Diseases|August 6, 2008
Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability studyP J Mease, K Hobbs, A Chalmers, et al.
Pageof 4